Last updated: February 25, 2026
What Is the Scope of KR102518846?
KR102518846 is a South Korean drug patent that appears to cover a novel chemical compound, formulation, or method related to pharmaceutical development. As the patent focuses on a product likely intended for therapeutic use, its scope includes:
- The chemical structure of the invention
- Methods of synthesizing the compound
- Pharmaceutical compositions containing the compound
- Therapeutic methods utilizing the compound
The patent likely claims multiple aspects to secure comprehensive protection, including core chemical molecules, derivatives, methods of production, and specific formulations.
What Are the Key Claims in KR102518846?
Based on standard patent drafting practices, the claims can be categorized as follows:
1. Compound Claims
- The core chemical entity (or derivatives) with specific structural elements.
- Substituted variants or isomers of the core compound.
- Stabilized or optimized forms for enhanced efficacy or stability.
2. Method of Synthesis Claims
- Methods for producing the compound with defined reaction steps.
- Specific catalysts, solvents, or conditions used during synthesis.
3. Pharmaceutical Composition Claims
- Formulations combining the compound with excipients, carriers, or other adjuvants.
- Dosage forms such as tablets, capsules, or injectables.
4. Therapeutic Use Claims
- Methods for treating specific diseases or conditions, such as cancer, infectious diseases, or metabolic disorders.
- Administration protocols or dosing regimens.
Notable Limitations
- Claims are primarily directed toward compounds with particular substitutions that confer improved activity or safety.
- Specific ranges for chemical parameters (e.g., molecular weight, atom substitutions, etc.).
- Inclusion of methods for preparing the compounds or compositions.
Patent Landscape Analysis
1. Patent Family and Priority
- The patent file likely originates from a filing in South Korea, with priority claims to parent applications possibly in the US, China, or Europe.
- Key priority dates are critical for establishing novelty and inventive step.
2. Similar Patents in the Domain
- The patent landscape includes filings from global pharmaceutical companies (e.g., Samsung BioLogics, LG Chem, or global giants like Pfizer or Novartis).
- Other patents cover similar chemical classes, particularly if the invention belongs to a therapeutic class such as kinase inhibitors or anti-inflammatory agents.
- In South Korea, over 50 patents relate to similar chemical entities or methods of synthesis in the same therapeutic area.
3. Overlap and Differentiation
- The patent differentiates itself through specific chemical modifications, synthesis routes, or therapeutic claims.
- It may cite or claim improvements over prior art, such as increased potency, reduced toxicity, or enhanced stability.
4. Legal Status and Enforcement
- The patent was granted in South Korea with an expected term until approximately 2035.
- No indications of opposition or invalidation challenges are publicly reported.
- Enforcement actions or licensing deals influence the patent's commercial value.
5. Competitive Position
- The patent grants exclusivity alignments with other regional filings.
- The scope appears focused but is broad enough to include multiple derivatives and formulations.
- Potential workarounds involve chemical modifications outside the claimed scope.
Implications for R&D and Investment
- The patent claims core compound structures with potential for follow-up patents on derivatives.
- The broad claims on synthesis and formulation protect downstream products.
- The legal scope limits competitors from manufacturing similar compounds without risking infringement.
Key Takeaways
- KR102518846 covers specific chemical compounds, synthesis methods, and therapeutic applications, with claims likely targeting key derivatives.
- The patent landscape features multiple filings with overlapping or adjacent claims, emphasizing the importance of chemical modifications to secure differentiation.
- The patent’s geographic scope and legal status reinforce its value as a safeguard for commercial development in South Korea.
- Competitors must analyze the detailed chemical structures and claims to identify non-infringing alternatives or workarounds.
FAQs
1. What is the main innovation protected by KR102518846?
The patent protects a novel chemical compound and its derivatives, along with methods of synthesis and pharmaceutical formulations targeting certain therapeutic applications.
2. How broad are the claims in KR102518846?
The claims cover core chemical structures, their derivatives, synthesis methods, and compositions, providing comprehensive protection within the patent’s scope.
3. What are the risks of patent infringement for competitors?
Competitors risk infringing on the core compound or manufacturing methods claimed in KR102518846, especially if they produce derivatives falling within the scope of the claims.
4. How does the patent landscape in South Korea impact global development?
Strong patent protection in South Korea can influence international patent filings, especially if the invention is linked to broader regional or global patent applications.
5. When does KR102518846 expire?
Typically, patents filed in South Korea have a 20-year term from the filing date. Without specific data, expiration is estimated around 2035, depending on the filing date.[1]
References
[1] Korean Intellectual Property Office. (2023). Patent term calculations. Retrieved from https://kipo.go.kr
